Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade
eLife · 01.09.2026 · 12
DOI: 10.7554/elife.91792 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 01.09.2026. Verfasst von Hengqi Betty Zheng und 45 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Seattle Children's Hospital and University of Washington, Seattle, United States. Hauptthemen laut MEDLINE: Crohn Disease, Tumor Necrosis Factor-alpha, Tumor Necrosis Factor Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Crohn’s disease is an inflammatory bowel disease (IBD) commonly treated through anti-TNF blockade. However, most patients still relapse and inevitably progress. Comprehensive single-cell RNA-sequencing (scRNA-seq) atlases have largely sampled patients with established treatment-refractory IBD, limiting our understanding of which cell types, subsets, and states at diagnosis anticipate disease severity and response to treatment. Here, through combining clinical, flow cytometry, histology, and scRNA-seq methods, we profile diagnostic human biopsies from the terminal ileum of treatment-naive pediatric patients with Crohn’s disease (pediCD; n = 14), matched repeat biopsies (pediCD-treated; n = 8) and from non-inflamed pediatric controls with functional gastrointestinal disorders (FGIDs; n = 13). To resolve and annotate epithelial, stromal, and immune cell states among the 201,883 baseline single-cell transcriptomes, we develop a principled and unbiased tiered clustering approach, ARBOL. Through flow cytometry and scRNA-seq, we observe that treatment-naive pediCD and FGID have similar broad cell type composition. However, through high-resolution scRNA-seq analysis and microscopy, we identify significant differences in cell subsets and states that arise during pediCD relative to FGID. By closely linking our scRNA-seq analysis with clinical meta-data, we resolve a vector of T cell, innate lymphocyte, myeloid, and epithelial cell states in treatment-naive pediCD (pediCD-TIME) samples, which can distinguish patients along the trajectory of disease severity and anti-TNF response. By using ARBOL with integration, we position repeat on-treatment biopsies from our patients between treatment-naive pediCD and on-treatment adult CD. We identify that anti-TNF treatment pushes the pediatric cellular ecosystem toward an adult, more treatment-refractory state. Our study jointly leverages a treatment-naive cohort, high-resolution principled scRNA-seq data analysis, and clinical outcomes to understand which baseline cell states may predict Crohn’s disease trajectory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Seattle Children's Hospital and University of Washington, Seattle, United States.
- Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, United States.
- Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, United States.
- Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, United States.
- Ragon Institute of MGH, MIT and Harvard, Cambridge, United States.
- Broad Institute of MIT and Harvard, Cambridge, United States.
ORCID-Profile: Hengqi Betty Zheng, Matthew F Wipperman, Wei Keat Lim, Lauren V Collen, Jose Ordovas-Montanes, Leslie S Kean
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NIDDK NIH HHS
- Harvard Digestive Diseases Center, Harvard University
- National Institute of Health
- AGA Research Foundation
- International mobility of research, technical and administrative staff of research organizations
- Leona M. and Harry B. Helmsley Charitable Trust
Zitieren
APA
Zheng, H. B., Doran, B. A., Kimler, K., Yu, A., Tkachev, V., Niederlova, V., Cribbin, K., Fleming, R., Bratrude, B., Betz, K., Cagnin, L., McGuckin, C., Keskula, P., Albanese, A., Sacta, M., de Sousa Casal, J., van Esch, R., Kwong, A. C., Kummerlowe, C., …, & Kean, L. S. (2026). Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade. eLife, 12. https://doi.org/10.7554/elife.91792
Vancouver
Zheng HB, Doran BA, Kimler K, Yu A, Tkachev V, Niederlova V, et al. Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade. eLife. 2026;12. doi:10.7554/elife.91792
BibTeX
@article{Zheng2026,
author = {Zheng, Hengqi Betty and Doran, Benjamin A and Kimler, Kyle and Yu, Alison and Tkachev, Victor and Niederlova, Veronika and Cribbin, Kayla and Fleming, Ryan and Bratrude, Brandi and Betz, Kayla and Cagnin, Lorenzo and McGuckin, Connor and Keskula, Paula and Albanese, Alexandre and Sacta, Maria and de Sousa Casal, Joshua and van Esch, Ruben and Kwong, Andrew C and Kummerlowe, Conner and Taliaferro, Faith and Fiaschi, Nathalie and Kou, Baijun and Coetzee, Sandra and Jalal, Sumreen and Yabe, Yoko and Dobosz, Michael and Wipperman, Matthew F and Hamon, Sara C and Kalliolias, George D and Hooper, Andrea and Lim, Wei Keat and Haxhinasto, Sokol and Wei, Yi and Ford, Madeline and Ambartsumyan, Lusine and Suskind, David L and Lee, Dale and Deutsch, Gail H and Deng, Xuemei and Collen, Lauren V and Mitsialis, Vanessa and Snapper, Scott B and Wahbeh, Ghassan and Shalek, Alex K and Ordovas-Montanes, Jose and Kean, Leslie S},
title = {Concerted changes in the pediatric single-cell intestinal ecosystem before and after anti-TNF blockade},
journal = {eLife},
year = {2026},
volume = {12},
doi = {10.7554/elife.91792}
}
EUVIMED